diltiazem has been researched along with mcn 5691 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almond, HR; Brannan, MD; Carmosin, RJ; Carson, JR; Flaim, SF; Gill, A; Gleason, MM; Keely, SL; Ludovici, DW; Pitis, PM | 1 |
| Schleifer, KJ; Tot, E | 1 |
2 other study(ies) available for diltiazem and mcn 5691
| Article | Year |
|---|---|
2-Ethynylbenzenealkanamines. A new class of calcium entry blockers.
Topics: Alkynes; Amines; Animals; Calcium Channel Blockers; Coronary Circulation; Guinea Pigs; Hypertension; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Vasodilation | 1988 |
Pharmacophore modelling of structurally unusual diltiazem mimics at L-type calcium channels.
Topics: Binding Sites; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Diltiazem; DOM 2,5-Dimethoxy-4-Methylamphetamine; In Vitro Techniques; Isoquinolines; Models, Molecular; Molecular Conformation; Oximes; Papaverine; Propylamines; Static Electricity | 2000 |